Crinetics Pharmaceuticals (CRNX) Stock Chart & Stock Price History $56.06 -0.97 (-1.70%) (As of 11/22/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Crinetics Pharmaceuticals Stock Price Performance 5 Day Performance+1.61%1 Month Performance-4.56%3 Month Performance+5.48%6 Month Performance+18.10%Year-To-Date Performance+57.56%1 Year Performance+75.24% Receive CRNX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Popular Stocks at Risk Under Trump—Are You Holding These? (Ad)The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely to lose big time now that Donald Trump has been re-electedClaim your copy before they move CRNX Stock Chart for Sunday, November, 24, 2024 CRNX Chart by TradingView Crinetics Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/22/2024$57.10$56.06-1.82%$57.10$55.341.04 million shs$5.20 billion11/21/2024$56.07$57.10+1.83%$58.04$55.51502,616 shs$5.30 billion11/20/2024$55.17$56.07+1.63%$56.43$54.64493,583 shs$5.20 billion11/19/2024$53.70$55.17+2.74%$55.21$53.15604,299 shs$5.12 billion11/18/2024$54.72$53.70-1.86%$55.05$52.85769,960 shs$4.98 billion11/15/2024$59.66$54.72-8.28%$60.15$54.42908,869 shs$5.07 billion Get the Latest News and Ratings for CRNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/14/2024$58.92$59.66+1.26%$62.53$58.17856,455 shs$4.77 billion11/13/2024$58.78$58.92+0.24%$61.16$58.501.14 million shs$4.72 billion11/12/2024$60.01$58.78-2.05%$60.48$58.21934,944 shs$4.70 billion11/11/2024$60.69$60.01-1.12%$62.00$59.95559,247 shs$4.80 billion11/08/2024$59.81$60.69+1.47%$60.92$58.98573,323 shs$4.86 billion11/07/2024$59.16$59.81+1.10%$60.17$58.66678,952 shs$4.79 billion11/06/2024$57.81$59.16+2.34%$60.91$58.621.04 million shs$4.73 billion11/05/2024$56.82$57.81+1.74%$57.88$55.28326,968 shs$4.63 billion11/04/2024$56.69$56.82+0.23%$58.00$55.21437,940 shs$4.55 billion11/01/2024$55.96$56.69+1.30%$57.81$56.19356,950 shs$4.54 billion10/31/2024$55.76$55.96+0.36%$56.54$54.32545,550 shs$4.41 billion10/30/2024$56.26$55.76-0.89%$56.95$55.44389,240 shs$4.40 billion10/29/2024$57.15$56.26-1.56%$57.24$56.12462,313 shs$4.44 billion10/28/2024$57.96$57.15-1.40%$59.67$56.82545,025 shs$4.51 billion10/25/2024$58.74$57.96-1.33%$59.32$57.86400,871 shs$4.57 billion10/24/2024$58.40$58.74+0.58%$59.39$58.30398,312 shs$4.63 billion10/23/2024$59.61$58.40-2.03%$59.94$57.54570,148 shs$4.61 billion Related Companies Ionis Pharmaceuticals Stock Chart Avadel Pharmaceuticals Stock Chart Bicycle Therapeutics Stock Chart Teva Pharmaceutical Industries Stock Chart BeiGene Stock Chart Viatris Stock Chart Moderna Stock Chart Summit Therapeutics Stock Chart Genmab A/S Stock Chart Dr. Reddy's Laboratories Stock Chart Receive CRNX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CRNX) was last updated on 11/24/2024 by MarketBeat.com Staff From Our Partners[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crinetics Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Crinetics Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free crnx Stock Alerts